Basal & Squamous Cell Skin Cancers in Adults

We established one of the first treatment programs in the New York City area for basal and squamous cell cancers, also called nonmelanoma skin cancers. Our dermatologists’ expertise in identifying and removing precancerous growths helps prevent many of these skin cancers from developing. When cancer is diagnosed, our medical oncologists, surgical oncologists, and radiation oncologists work together to provide the most effective treatment. Our reconstructive surgeons and rehabilitation doctors may also play an important role in your care.

Clinical Trials and Research Studies

Phase 2

A Phase 2 Study of REGN2810 a Fully Human Monoclonal Antibody to Programmed Death-1 in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor therapy

Phase 1

A Multicenter Two Part Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination with Pembrolizumab in Subjects with Advanced Melanoma

Phase 1

A Phase 1 First-in-Human Open Label Dose Escalation Study of MGD009 A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART ) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses

Phase 3

A randomized double-blind placebo-controlled phase III study comparing the combination of PDR001 dabrafenib and trametinib versus placebo dabrafenib and trametinib in previously untreated patients with unresectable or metastatic BRAF V600 mutant melanoma